AJP - Heart AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 277: H2458-H2469, 1999;
0363-6135/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gysembergh, A.
Right arrow Articles by Przyklenk, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gysembergh, A.
Right arrow Articles by Przyklenk, K.
Vol. 277, Issue 6, H2458-H2469, December 1999

SPECIAL TOPIC
Pharmacological manipulation of Ins(1,4,5)P3 signaling mimics preconditioning in rabbit heart

Anne Gysembergh1, Stéphanie Lemaire2, Christophe Piot2, Catherine Sportouch2, Sylvain Richard2, Robert A. Kloner1, and Karin Przyklenk1

1 Heart Institute, Good Samaritan Hospital and University of Southern California, Los Angeles, California 90017-2395; and 2 Institut de Génétique Humaine, Centre National de la Recherche Scientifique, UPR 1142, Montpellier, France

Recent evidence revealed biphasic alterations in myocardial concentrations of the second messenger inositol (1,4,5)-trisphosphate [Ins(1,4,5)P3] with ischemic preconditioning (PC), i.e., increase during brief PC ischemia and decrease early during sustained test occlusion. Our aim was to determine whether an agonist and an antagonist of Ins(1,4,5)P3 signaling {D-myo-inositol-1,4,5-trisphosphate hexasodium salt [D-myo-Ins(1,4,5)P3] and 2-aminoethoxydiphenyl borate (2-APB), respectively}, given such that they mimic this biphasic profile, would mimic infarct size reduction with PC. To test this concept, isolated, buffer-perfused rabbit hearts received no intervention (control), ischemic PC, D-myo-Ins(1,4,5)P3, D-myo-Ins(1,4,5)P3 + PC, 2-APB, or 2-APB + PC. All hearts then underwent 30-min coronary occlusion and 2 h reflow, and infarct size was delineated by tetrazolium staining. In addition, the effects of D-myo-Ins(1,4,5)P3 and 2-APB on Ins(1,4,5)P3 signaling were evaluated in isolated fura 2-loaded rat cardiomyocytes. Mean infarct size was reduced with PC and in all D-myo-Ins(1,4,5)P3- and 2-APB-treated groups versus control (59 and 42-55%, respectively, vs. 80% of myocardium at risk, P < 0.05). Thus pharmacological manipulation of Ins(1,4,5)P3 signaling mimics the cardioprotection achieved with ischemic PC in rabbit heart.

myocardial ischemia; myocardial infarction; signal transduction; 2-aminoethoxydiphenyl borate; calcium


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
I. B. Nicoud, C. D. Knox, C. M. Jones, C. D. Anderson, J. M. Pierce, A. E. Belous, T. M. Earl, and R. S. Chari
2-APB protects against liver ischemia-reperfusion injury by reducing cellular and mitochondrial calcium uptake
Am J Physiol Gastrointest Liver Physiol, September 1, 2007; 293(3): G623 - G630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Przyklenk, M. Maynard, and P. Whittaker
First molecular evidence that inositol trisphosphate signaling contributes to infarct size reduction with preconditioning
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H2008 - H2012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Przyklenk, M. Maynard, and P. Whittaker
Reduction of infarct size with D-myo-inositol trisphosphate: role of PI3-kinase and mitochondrial KATP channels
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H830 - H836.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. E. Darling, R. Jiang, M. Maynard, P. Whittaker, J. Vinten-Johansen, and K. Przyklenk
Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1618 - H1626.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Barrere-Lemaire, N. Combes, C. Sportouch-Dukhan, S. Richard, J. Nargeot, and C. Piot
Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P3 signaling pathway in rat ventricular myocytes
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H83 - H88.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. D. BOOTMAN, T. J. COLLINS, L. MACKENZIE, H. L. RODERICK, M. J. BERRIDGE, and C. M. PEPPIATT
2-Aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release
FASEB J, August 1, 2002; 16(10): 1145 - 1150.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. A. Powell, M. A. Carrasco, D. S. Adams, B. Drouet, J. Rios, M. Muller, M. Estrada, and E. Jaimovich
IP3 receptor function and localization in myotubes: an unexplored Ca2+ signaling pathway in skeletal muscle
J. Cell Sci., March 12, 2002; 114(20): 3673 - 3683.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Dobrydneva and P. Blackmore
2-Aminoethoxydiphenyl Borate Directly Inhibits Store-Operated Calcium Entry Channels in Human Platelets
Mol. Pharmacol., September 1, 2001; 60(3): 541 - 552.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. M. Chilian and G. J. Gross
Prologue: ischemic preconditioning in cardiac vascular muscle
Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2416 - H2417.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online